Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching from rHuEPO to intravenous R744 in hemodialysis patients with renal anemia
jRCT2080220219Phase 2
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of Carbon dioxide in anemia of renal disease, sponsored by Chugai Pharmaceutical Co., Ltd.
02
Drugs
Carbon dioxide
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on jRCT2080220219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220219.